Evidence map›Paper›PMID 41777544›Full record

ArticleFrontiers in microbiology2026

Evaluation of probiotic properties and genome analysis of the new

Polina Makarycheva, Vincenzo Bellitto, Aristide Toussaint Nguele, Chiara Salvesi, Matteo Mozzicafreddo, Anna-Rita Attili, Dennis Fiorini, Daniele Tomassoni, Stefania Silvi, Cristina Miceli

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Polina MakarychevaSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Vincenzo BellittoSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Aristide Toussaint NgueleSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Chiara SalvesiSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Matteo MozzicafreddoDepartment of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
Anna-Rita AttiliSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Dennis FioriniSchool of Sciences and Technologies, University of Camerino, Camerino, Italy.
Daniele TomassoniSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Stefania SilviSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Cristina MiceliSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The human gut microbiota plays a key role in intestinal homeostasis and inflammatory diseases, prompting the search for novel probiotic strains with strain-specific functional properties. Differences in dietary habits and cultural backgrounds represent a valuable source for isolating previously uncharacterized gut bacteria. Given the increasing use of probiotics, rigorous safety assessment, including antimicrobial resistance (AMR) evaluation, is required, and the integration of whole-genome sequencing with phenotypic characterization is recommended. Objectives: This study evaluated the probiotic potential of Methods: Strain identification was performed by MALDI-TOF mass spectrometry and 16S rRNA gene sequencing. Results: Conclusion:

Indexed as

bacterialgenomechemical-induced colitisgut microbiotaintestinal mucosalactic acid bacteriaprobiotics

Identifiers

PMID41777544
PMCPMC12951473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.